Search clinical trials for: First Nations

Total 16022 results

Technical University of Munich

Withdrawn

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Breast Cancer

Germany
Telik

Completed

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Centocor, Inc.

Completed

A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors

Cancer

United States, Spain
Eli Lilly and Company

Completed

A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Singapore
Fudan University

Completed

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Esophageal Squamous Cell Carcinoma
QLT Inc.

Terminated

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Stage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
QLT Inc.

Terminated

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Stage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
Nanjing Medical University

Completed

The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

Atrial Fibrillation

China
University of Washington
National Institute of Mental Health (NIMH)

Completed

Promoting Infant Mental Health in Foster Care

Child Development | Child Behavior Disorders | Reactive Attachment Disorder

United States
Qi-Yong Li

Completed

Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique

Biliary Diseases | Pancreas Diseases

China
Veeda Oncology
Bayer; Celgene Corporation

Terminated

A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
Veeda Oncology
Celgene Corporation

Completed

A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer

United States
RTI International
National Institute on Drug Abuse (NIDA)

Terminated

First in Humans Study of JDTic

Cocaine Dependence

United States
Novartis Pharmaceuticals

Completed

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Diabetes Mellitus, Type 2

China
Mashhad University of Medical Sciences
Roche Pharma AG

Completed

Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis

DMARD Resistant Rheumatoid Arthritis

Iran, Islamic Republic of
Oslo University Hospital

Completed

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Mantle Cell Lymphoma

Norway
Novartis Pharmaceuticals

Completed

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

Compensated Chronic Hepatitis B

China
Zhengzhou University
The First Affiliated Hospital of Zhengzhou University; Xinyang Central Hospital and other collaborators

Unknown

Radiotherapy vs Observation for CRPC

Hormone Refractory Prostate Cancer

China
Gilead Sciences

Completed

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Neoplasms

United States
Abbott

Completed

A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
Novartis Pharmaceuticals

Terminated

Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment

Metastatic Breast Cancer
Galapagos NV

Completed

First-in-Human Exploratory Single Ascending Dose of GLPG0974

Healthy

Belgium
Ablynx

Terminated

First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4

Healthy Volunteers

Netherlands
Novartis

Completed

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)

Relapsing-remitting Multiple Sclerosis

Canada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
Chinese PLA General Hospital
General Hospital of Chinese Armed Police Forces; Beijing Shijitan Hospital,... and other collaborators

Unknown

Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome

Acute Lung Injury | Respiratory Distress Syndrome, Adult

China
Changchun Huayang High-tech Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Alzheimer's Disease

China
GlaxoSmithKline

Completed

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Society for Applied Studies
The Research Council of Norway; World Health Organization; United Nations; Society...

Completed

Impact of the Integrated Management of Neonatal and Childhood Illness Strategy on Neonatal and Infant Mortality (IMNCI-India)

Mortality

India
Fujian Medical University

Unknown

Risk Factors for Aneurysm Rebleeding

Subarachnoid Hemorrhage, Aneurysmal

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University

Unknown

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Colorectal Cancer

China
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma (mXELOX)

Colorectal Adenocarcinoma

China
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma (mSOX)

Gastric Adenocarcinoma

China
National University Hospital, Singapore

Completed

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

Solid Tumors

Singapore
Shandong University
The Second Hospital of Hebei Medical University; Sun Yat-Sen Memorial Hospital... and other collaborators

Unknown

Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART

Infertility

China
Pfizer

Completed

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Advanced Solid Tumors

United States
Wenzhou Medical University

Unknown

ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis

Liver Cirrhosis | Surgery | Portal Hypertension | Hepatic Decompensation

China
University of Aarhus
The Danish Medical Research Council

Completed

Brain Swelling During Dialysis (BRASE)

End Stage Renal Disease

Denmark
University College, London
Merck Sharp & Dohme LLC

Withdrawn

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma (MESO-02)

Malignant Pleural Mesothelioma
UCB Pharma

Completed

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Pharmacokinetics

Germany
First People's Hospital of Foshan

Unknown

Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites

Liver Cirrhosis | Refractory Ascites

China
GlaxoSmithKline

Completed

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Healthy Subjects | Anaemia

Australia
GlaxoSmithKline

Completed

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Premature Ejaculation | Obstetric Labour, Premature

United States
Grupo Oncológico Gallego
Pivotal S.L.

Unknown

Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

Breast Cancer

Spain
Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Nanchang University; Nanjing Medical University and other collaborators

Unknown

Treatment of Unstable Distal Clavicular Fractures (Neer 2b): Hook Plate vs Locking Plate

Clavicle Injuries

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Beijing YouAn Hospital; China Academy of Chinese Medical Sciences; Beijing University... and other collaborators

Completed

Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease

Hand, Foot, and Mouth Disease

China
Fudan University
Zhejiang Cancer Hospital; RenJi Hospital; First People Hospital of Zhejiang

Unknown

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Rectal Cancer

China
Genta Incorporated

Unknown

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

Gastric Carcinoma

Korea, Republic of
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

Breast Cancer

Greece
Juniper Pharmaceuticals, Inc.
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

PREGNANT Short Cervix Trial

Preterm Delivery | Short Cervix | Short Uterine Cervical Length

United States, Israel, Belarus, Chile, Czech Republic, India, Italy, Russian Federation, South Africa, Ukraine

Search clinical trials for: First Nations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations